Question 1

Who is Aubrey Rankin?

Accepted Answer

Aubrey Rankin serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 19 insider transactions totaling $9.1M over their tenure at the company.

Question 2

What is Aubrey Rankin's role at Revance Therapeutics, Inc.?

Accepted Answer

Aubrey Rankin holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.

Question 3

Is Aubrey Rankin buying or selling RVNC stock?

Accepted Answer

Aubrey Rankin has shown a selling trading pattern, with $432.9K in total purchases and $8.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Aubrey Rankin's largest insider transactions?

Accepted Answer

The largest transaction by Aubrey Rankin was on Jul 26, 2021, when they sold $1.6M worth of RVNC shares. This transaction involved 55,382 shares at $29.72 per share.

Question 5

What is Aubrey Rankin's trading accuracy?

Accepted Answer

Aubrey Rankin has a Personal Accuracy Score of 74/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Aubrey Rankin associated with?

Accepted Answer

Aubrey Rankin has filed Form 4 transactions for 1 different company. Their primary association is with Revance Therapeutics, Inc. (RVNC), where they serve as Executive.

Question 7

How much RVNC stock does Aubrey Rankin own?

Accepted Answer

Aubrey Rankin currently owns 94,091 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Aubrey Rankin's equity in Revance Therapeutics, Inc.?

Accepted Answer

Aubrey Rankin's equity position in Revance Therapeutics, Inc. consists of 94,091 shares valued at approximately $0. As Executive, they have executed 19 insider transactions, with $432.9K in purchases and $8.7M in sales.

Question 9

Where can I find Aubrey Rankin's SEC Form 4 filings?

Accepted Answer

All of Aubrey Rankin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aubrey Rankin has 19 Form 4 filings on record as an insider at Revance Therapeutics, Inc..

Question 10

What is Aubrey Rankin's net worth from RVNC?

Accepted Answer

Based on their current RVNC stock holdings, Aubrey Rankin has equity worth approximately $0 in Revance Therapeutics, Inc.. This value is based on 94,091 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Mar 15, 2022	RVNC	$21.7K	Payment	1,372	$15.79	Discretionary
Dec 3, 2021	RVNC	$432.9K	Purchase	30,000

Aubrey Rankin

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Aubrey Rankin Trading Summary

How Much RVNC Stock Does Aubrey Rankin Own?

Is Aubrey Rankin Buying or Selling RVNC?

Aubrey Rankin's Recent Stock Transactions

Frequently Asked Questions

Track Aubrey Rankin's Trades